Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID‐19 pandemic: The real‐world experience of a single center – Onsun – – Dermatologic Therapy
1 INTRODUCTION Etanercept is a tumor necrosis factor (TNF) antagonist approved for the treatment of psoriatic arthritis and psoriasis. The ...











